TrialEuropean journal of nuclear medicine and molecular imaging2005

Dual-phase 18F-fluoro-2-deoxy-D-glucose positron emission tomography as a prognostic parameter in patients with pancreatic cancer.

Andrej Lyshchik et al.PubMed ↗Publisher ↗

No numbers read from the abstract.